Constant Therapy Health

What Constant Therapy Health does

Constant Therapy Health is a private digital therapeutics company founded in 2014 (originally as The Learning Corp) and headquartered in Lexington, Massachusetts. The company develops Constant Therapy, an AI-driven mobile and web application that delivers personalized speech, language, and cognitive therapy exercises to patients recovering from stroke, traumatic brain injury, aphasia, dementia, and other neurological conditions. The platform is powered by the patented NeuroPerformance Engine (NPE), which uses machine learning and population-level performance data from more than 140 million completed exercises to adapt exercise difficulty and selection to each user's diagnosis, severity, and progress. The product has been granted FDA Breakthrough Device designation for its Speech Therapy app, the first cognitive linguistics app to receive this regulatory status.

The company sells through a three-tier subscription model: a direct-to-consumer Patient tier at $29.99 per month after a 14-day free trial, a Partner Program for individual clinicians and small practices at $360 per clinician per year, and an Enterprise tier for hospitals, health systems, and large clinics with custom pricing, SSO, BAA, and population-level reporting. Distribution is hybrid: self-serve via the iOS App Store and Google Play for patients, and sales-led for institutional customers, with named partners including Burke Rehabilitation, VitalCaring, Elara Caring, Aviv Scientific, and Boundless AT, plus research collaborations with Boston University, University of Rochester, and University of Texas. The platform is available in English (US), English (India), and Spanish (US), and the company supports US and India operations via dedicated support lines.

Constant Therapy Health has raised approximately $30M in disclosed funding, most recently a $27.3M round in 2019. The company is led by founders Veera Anantha (CEO), Mahendra Advani (CTO), and Dr. Swathi Kiran (Founding Scientist, Boston University), and has been recognized among TIME's World's Top HealthTech Companies of 2025 and as a winner of the Hearst Health Prize. Its competitive position rests on the patented NPE, a regulatory moat from the FDA Breakthrough Device designation, a comprehensive evidence-based exercise library, and a growing real-world dataset.

Name

Constant Therapy Health

Legal name

Constant Therapy Health

Website

https://constanttherapyhealth.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Constant Therapy Health is a Boston-based digital therapeutics company that delivers AI-personalized speech, language, and cognitive therapy to patients recovering from stroke, TBI, aphasia, and other neurological conditions via its patented NeuroPerformance Engine and FDA Breakthrough-designated app.

Ownership category

akta.pro rank

Product category

Digital Therapeutics / Healthcare AI Software

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Services for the Elderly and Persons with Disabilities (62412)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Home Health Care Services (8082), Services-Prepackaged Software (7372)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industries

Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK), Cognitive-Communication & Memory Rehab Therapy In-Home (HSABADAL)

Keywords

• Digital therapeutics
• Speech therapy software
• Cognitive rehabilitation
• Clinical AI platform
• Neurorehabilitation technology

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Patient Subscription: Individual patients pay $29.99/month for unlimited access to the Constant Therapy app after a 14-day free trial. Revenue generated through recurring monthly subscriptions with 30-day money-back guarantee.
2. Partner Program - Clinicians: Individual clinicians or small practices (fewer than 5 clinicians) pay $360 per clinician annually for access to the Constant Therapy Clinician App with unlimited patients, progress reports, and patient management features.
3. Enterprise Licensing: Mid-size and large healthcare entities pay variable fees based on number of users for enterprise features including population-level reporting, admin dashboards, SSO, BAA, and dedicated account managers.
4. Technology Licensing: Licensing the Constant Therapy technology platform to healthcare enterprises, research institutions, and care delivery organizations through custom-built versions.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Constant Therapy Health develops and sells an AI-driven digital therapeutics platform called Constant Therapy that delivers personalized speech, language, and cognitive therapy exercises for individuals recovering from stroke, traumatic brain injury, aphasia, dementia, and other neurological conditions. The platform is offered to individual patients as a mobile subscription app, to speech-language pathologists via a clinician app, and to healthcare institutions (hospitals, health systems, clinics) through enterprise licensing with HIPAA-compliant security, population-level reporting, and EMR-ready documentation.

Product overview

Constant Therapy Health offers Constant Therapy, an AI-driven digital therapeutics platform for brain health. The core product suite includes: (1) Constant Therapy Patient App for direct consumer use with 80+ evidence-based speech, language, and cognitive exercises; (2) Constant Therapy Clinician for speech-language pathologists to assign and monitor therapy; (3) Constant Therapy Enterprise for institutional deployment across hospitals and clinics with HIPAA-compliant security, admin controls, and EMR documentation; and (4) the NeuroPerformance Engine (NPE), the patented AI technology powering all products that delivers personalized exercise recommendations by analyzing individual performance against population data. The platform is complemented by the BrainWire educational blog and is available in English (US), English (India), and Spanish (US).

Differentiator

Problem solved

Functional benefit

Brands

• Constant Therapy Enterprise: Enterprise solution for clinics and healthcare organizations providing cognitive and speech therapy with HIPAA-compliant features, admin controls, and EMR-ready documentation.
• Constant Therapy Clinician
• Constant Therapy Patient App

Products and services

• Constant Therapy Patient App Mobile application for individuals recovering from stroke, traumatic brain injury, aphasia, dementia, and other neurological conditions. Provides 24/7 access to over 80 evidence-based speech, language, and cognitive therapy exercises across 14+ categories with adaptive difficulty that adjusts based on the user's performance and progress. Available on smartphone, tablet, and Chromebook.
• Constant Therapy Clinician Evidence-based digital program for speech-language pathologists (SLPs) and adult speech therapists to deliver interactive cognitive and speech therapy in clinic and assign personalized home exercise programs to patients. Includes detailed progress reporting, auto-generated clinical documentation, and caseload management features.
• Constant Therapy Enterprise Institutional deployment of the Constant Therapy platform for hospitals, rehabilitation centers, health systems, and large clinics. Includes unlimited patients, population-level reporting, admin dashboard, priority support, SSO, MFA, password policy, IP whitelisting, Business Associates Agreement (BAA), flexible license assignment, and EMR-ready auto-generated clinical documentation. Sold via custom multi-year contracts through the enterprise sales team.

Quantifiable outcome

• 4x more therapy delivered compared to clinic-only care
• +4 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature5 records

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Pear Therapeutics: Pear Therapeutics was a pioneer in prescription digital therapeutics (reSET, reSET-O) for substance use disorder and opioid use disorder. It is a relevant direct peer in FDA-authorized digital therapeutics, though it filed for bankruptcy in 2023, illustrating the commercial challenges in the category.
• MedRhythms: MedRhythms builds digital therapeutics for neurologic conditions, focusing on gait and walking recovery post-stroke using sensor-based interventions. It is a direct peer in prescription digital therapeutics for neurorehabilitation.
• Posit Science (BrainHQ): Posit Science offers BrainHQ, an evidence-based cognitive training platform with clinician and consumer versions. It is directly comparable as a digital cognitive training product serving both patients recovering from neurological conditions and healthy adults seeking cognitive improvement.
• Akili Interactive: Akili Interactive (now folded into Virtual Therapeutics) develops FDA-cleared digital therapeutics for cognitive dysfunction, including EndeavorRx for ADHD. It is a direct peer as a prescription and consumer digital therapeutic targeting neurological and cognitive conditions.
• Big Health: Big Health develops digital therapeutics for mental health conditions such as insomnia (Sleepio) and anxiety. It is comparable as a digital therapeutics company with both consumer and enterprise/health plan distribution and FDA-recognized evidence base.

Emerging players

• Limbic: Limbic is a UK-based AI mental health platform used by NHS talking therapy services for patient intake, triage, and outcome measurement. It is an emerging player using AI in behavioral health workflows, with overlapping technology and clinical use cases though focused on mental health rather than neurocognitive rehab.

Broad incumbents

• Teladoc Health: Teladoc Health operates a broad virtual care platform spanning general telehealth, mental health, and chronic condition management. It is comparable as a large incumbent digital health player that health systems and employers buy alongside or against Constant Therapy.
• Omada Health: Omada Health provides digital care programs for chronic conditions (diabetes, hypertension, musculoskeletal). It is a broad incumbent in digital therapeutics selling to employers and health plans, comparable in enterprise GTM and evidence-based care delivery.
• Headspace Health: Headspace Health (Headspace + Ginger) offers a broad mental health and wellness platform including therapy, coaching, and meditation. It is comparable as a digital health company serving consumers and enterprises with brain/mental health content, though its scope is broader than neurocognitive rehabilitation.
• Talkspace: Talkspace is an online therapy platform connecting users to licensed therapists via text, audio, and video. It is comparable as a digital mental/behavioral health platform selling to both consumers and enterprises/B2B partners, though its modality is live human therapy rather than AI-driven exercises.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ConstantTherapy
• YouTubeyoutube.com/channel/UCJT65S6EvNEsb10w2zrESIQ
• Facebookfacebook.com/ConstantTherapy
• LinkedInlinkedin.com/company/constant-therapy
• Instagraminstagram.com/_constant.therapy
• Pinterestpinterest.com/constantthe0461

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds5 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Constant Therapy Health